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Bulletin 3Drug Use in Ireland 
and Northern Ireland
2002/2003 Drug Prevalence Survey: Cannabis Results
Previously published findings in Drug Use in Ireland and Northern Ireland: First Results (Revised) from the 2002/2003 Drug
Prevalence Survey (Bulletin 1) showed that cannabis was the most commonly used illegal drug in both Ireland and Northern
Ireland across all time periods, lifetime (ever used), last year (recent use) and last month (current use).
This bulletin contains results relating to cannabis prevalence on a lifetime (ever used), last year (recent use), and last month
(current use) in Ireland and Northern Ireland. It also examines age of first use; regular use; type of cannabis used; method by
which cannabis is used; how and where cannabis is obtained; reasons for stopping use; attitudes to cannabis use and perceptions
of risk, together with the most common characteristics of typical cannabis users.
IRELAND – Key Findings
■ Prevalence rates were higher among
younger respondents – the lifetime
prevalence rate for those aged 15 to 
34 (24%) was more than double that
for those aged 35 to 64 (11%).
■ Male respondents reported higher
prevalence rates than females across 
all time periods. The lifetime prevalence
figure for males was 22% compared to
12% for females.
■ The average age that respondents
reported that they had first used
cannabis was 18 years for both 
males and females. The average age 
of first regular use was 18 for males 
and 17 for females.
■ Almost a quarter (22%) of current 
users have used cannabis on a daily 
or almost daily basis.
■ Hash was the most commonly used
form of cannabis – used by 68% of
current users.
■ The majority of current users (98%)
consume cannabis using a joint.
■ Nearly one third of recent users (31%)
were given cannabis by a family member
or friend, a further 27% said they had
shared cannabis amongst a group of friends.
■ The vast majority of respondents (79%)
considered it ‘very easy’ or ‘fairly easy’ to
obtain cannabis within a 24 hour period.
■ Over a quarter (27%) of respondents
who said that they had ever taken
cannabis said that they had used it
regularly. Of these, almost three in 
five (58%) said that they had stopped
taking cannabis, one in eight (12%) said
that they had tried to stop and failed,
whilst three in ten (30%) respondents
said that they had never tried to stop.
■ A large majority (72%) of those 
surveyed felt that cannabis use should
be permitted for medical purposes.
■ Only 21% of respondents agreed that
cannabis use should be permitted for
recreational purposes. Thirteen percent
of those who had never used cannabis
agreed that recreational use should be
permitted, compared to 61% of those
who had ever used the drug.
NORTHERN IRELAND – 
Key Findings
■ Prevalence rates were higher among
younger respondents – the lifetime
prevalence for those aged 15 to 34
(25%) was more than double that 
for those aged 35 to 64 (10%).
■ Male respondents reported higher
prevalence rates than females across 
all time periods. The lifetime prevalence
figure for males was 23% compared 
to 11% for females.
■ The average age that respondents
reported that they had first used cannabis
was 18 years – females were slightly
older at 19 years compared to males at
18 years. The average age of first regular
use was also reported as 18 years old.
■ Almost a third (31%) of current users
said that they used cannabis on a daily
or almost daily basis.
■ Resin was the most commonly used
form of cannabis – used by almost half
(47%) of current users.
■ The majority of current users (91%)
consume cannabis in the form of a joint.
■ Two in five (39%) said that they shared
cannabis among a group of friends, 
a further 23% bought it from a friend.
■ Over half (55%) of recent users said
they had obtained cannabis at the house
of a friend, whilst 12% had obtained 
it in the street or park and 14% at a
disco/club/bar.
■ The vast majority (91%) of respondents
considered it ‘very easy’ or ‘fairly easy’ to
obtain cannabis within a 24 hour period.
■ Over a quarter (28%) of respondents
who said that they had ever taken
cannabis said that they had used it
regularly. Of these, almost half (48%)
said that they had stopped taking cannabis,
one in five (20%) said that they had tried
to stop and failed, whilst a third (33%) 
said that they had never tried to stop.
■ Over two in five (42%) of regular users
who stopped using cannabis said they
stopped because they did not want to take
it any more. More than a quarter (26%)
cited health concerns as their reason for
stopping using cannabis, whilst a quarter
(25%) said they stopped because cannabis
was no longer part of their social life.
■ Almost all (94%) of those who had 
ever used cannabis compared to three
quarters (76%) of those who had never
used cannabis, felt that cannabis use
should be permitted for medical reasons.
■ Two in three (63%) of those who had ever
used cannabis compared to one in seven
(14%) of those who had never used
cannabis, felt that cannabis use should
be permitted for recreational reasons.
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Introduction
The survey was commissioned by the National Advisory
Committee on Drugs (NACD) in Ireland and the Drug and
Alcohol Information and Research Unit (DAIRU) within the
Department of Health, Social Services and Public Safety
(DHSSPS) in Northern Ireland.
The main focus of the survey was to obtain prevalence 
rates for key illegal drugs, such as cannabis, ecstasy, cocaine, 
and heroin, on a lifetime (ever used), last year (recent use), 
and last month (current use) basis. Similar prevalence 
questions were also asked of alcohol, tobacco, and other 
drugs (e.g. tranquillisers); attitudinal and demographic
information was also sought from respondents.
Following open tender, the contract for conducting the 
survey was awarded to MORI MRC.
Methodology
The questionnaire and methodology for this survey were 
based on best practice guidelines drawn up by the EMCDDA. 
The questionnaires were administered through face-to-face
interviews with respondents aged between 15 and 64 years 
and who are normally resident in households in Ireland and
Northern Ireland. Thus persons outside these age ranges, 
or who do not normally live in private households, have not 
been included in the survey. This approach is commonly 
used throughout the EU and because of the exclusion of 
those living in institutions (for example prisons, nursing 
homes etc.) this type of prevalence survey is usually 
known as a general population survey.
Fieldwork for the survey was carried out between October 
2002 and April 2003 and the final achieved sample comprised
of 8,434 respondents (4,918 in Ireland and 3,516 in Northern
Ireland). The response rate for the survey was 70% in Ireland
and 63% in Northern Ireland.
The sample was weighted by gender, age, Health Board1 in
Ireland and Health and Social Services Board area in Northern
Ireland, to maximise its representativeness of the general
population.
Details of the methodology have been summarised in a paper
published on the websites of the NACD (http://www.nacd.ie/)
and the DHSSPS (http://www.dhsspsni.gov.uk/) and a
comprehensive technical report containing copies of the
questionnaires used in both jurisdictions will be published
separately.
What is Prevalence?
The term prevalence refers to the proportion 
of a population who have used a drug over a
particular time period. In general population
surveys, prevalence is measured by asking
respondents in a representative sample drawn
from the population to recall their use of drugs.
The three most widely used recall periods are:
lifetime (ever used a drug), last year (used a drug
in the last twelve months), and last month (used a
drug in the last 30 days). Provided that a sample is
representative of the total population, prevalence
information obtained from a sample can be used
to infer prevalence in the population.
Lifetime prevalence refers to the proportion 
of the sample that reported ever having used 
the named drug at the time they were surveyed. 
A person who records lifetime prevalence may 
or may not be currently using the drug. Lifetime
prevalence should not be interpreted as meaning
that people have necessarily used a drug over a
long period of time or that they will use the drug 
in future.
Last year prevalence refers to the proportion of
the sample that reported using a named drug in
the year prior to the survey. For this reason, last
year prevalence is often referred to as recent use.
Last month prevalence refers to the proportion 
of the sample that reported using a named drug 
in the 30 day period prior to the survey. Last month
prevalence is often referred to as current use. 
A proportion of those reporting current use may 
be occasional (or first-time) users who happen to
have used in the period leading up to the survey –
it should therefore be appreciated that current use
is not synonymous with regular use.
1 Since January 2005 the Health Boards in Ireland have undergone restructuring and are merged under one authority – the Health Service Executive. 
The above reference relates to the Health Board structure detailed in Bulletin 2: Drug Use in Ireland and Northern Ireland 2002/2003 Drug Prevalence Survey:
Health Board (Ireland) & Health and Social Services Board (Northern Ireland) Results (Revised).
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Understanding the Results 
of this Bulletin
Initial results from the Drug Prevalence Survey were published 
in Bulletin 1 (October 2003, revised June 2005), which gave
lifetime, last year, and last month prevalence rates for key 
drugs for the Island of Ireland, Ireland and Northern Ireland.
Bulletin 2, published in March 2004 (revised June 2005),
contained comparable information for Ireland and its constituent
Health Boards and Northern Ireland and its constituent Health
and Social Services Board areas. Prevalence rates for alcohol 
and tobacco (and, relating to Northern Ireland only, for anabolic
steroids and Nubain®) were also included in the tables.
This bulletin (Bulletin 3) contains prevalence rates for the use of
cannabis and other information relating to cannabis use in
Ireland and Northern Ireland. Results are given for all
respondents aged between 15 and 64, by gender and by age
(younger adults aged 15 to 34 and older adults aged 35 to 64).
Readers should note that the total sample size for each group 
is given at the head of each column. As in all sample surveys, 
the greater the sample size the more statistically reliable the
results become.
Invalid responses have been excluded from all analyses.
Percentages may not always sum to 100 due to either the 
effect of rounding or where respondents could give more than
one answer.
Statistical significance tests (Chi-Square Tests) have been carried
out on a range of variables. These tests are used to establish the
degree of confidence with which we can infer that the observed
findings are an accurate reflection of the views of the population.
In this bulletin, where test results have emerged as statistically
significant, this has been reported at the 5% level of probability
(p ≤ 0.05). Therefore, where a value of p less than or equal to
0.05 was found, we can be confident that 95 times out of 100
the differences that we have observed are real, i.e. not due to
sampling error.
In an attempt to compare prevalence rates for cannabis 
use across different social grades/socio-economic groups, 
the Standard Occupational Classification (SOC2000) was used.
The SOC2000 is based on the employment status, level of
responsibility and qualifications, of the chief income earner
within a household. Further information will be available 
in a technical report which will be published separately.
Respondents were then coded into the following social grades:
A (Professionals, senior management and top civil servants)
B (Middle management, senior civil servants, managers and
owners of businesses)
C1 (Junior management and owners of small businesses)
C2 (Skilled manual workers and manual workers responsible 
for other workers)
D (Semi-skilled and unskilled manual workers, trainees 
and apprentices)
E (All those dependant on the State long-term)
Future Publications
This is the third bulletin in a series that explores findings from 
the drug prevalence survey 2002/2003. Future bulletins will
include an analysis of polydrug use, use of psycho-stimulants
and an exploration of the socio-demographic profile of drug
users throughout the Island of Ireland. A detailed technical
report, including copies of the questionnaires used, will also 
be published.
Glossary
Bong
A water pipe through which the hot smoke is cooled down
before being inhaled.
Grass/Weed
Slang terms for herbal cannabis.
Hash, Hashish
Cannabis resin
Hash Oil
A purified and concentrated form of resin or herbal cannabis.
Herb
The fresh or (more commonly) dried leaves and flowering
tops of the plant.
Joint
A cannabis cigarette (also known as a spliff, reefer etc.)
Resin
Produced by separating the resinous parts of the plant 
from the leaves etc.
Skunk
A type of high-potency cannabis.
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Ireland
Prevalence of Cannabis Use (Table 1)
Almost one in six respondents (17%) aged 15 to 64 reported
that they had taken cannabis at some stage in their lives, with
5% having used in the last year and 3% having used in the 
last month.
Age (Table 1)
Overall, prevalence rates were higher among younger
respondents – the lifetime prevalence rate for those aged 
15 to 34 (24%) was more than double the rate for those aged
35 to 64 (11%). The last year prevalence rate for those aged 
15 to 34 (9%) was more than 4 times that for respondents
aged 35 to 64 (2%). Similarly, the rate for last month use was 
4 times higher for those aged 15 to 34 (4%) than for those
aged 35 to 64 (1%).
Gender (Table 1)
Male respondents reported higher prevalence rates than females
across all time periods. The lifetime prevalence figure for males
was 22% compared to 12% for females. Similarly, the figures 
for last year were males 7% and females 3%, whilst last month
prevalence rates were males 3% and females 2%.
First use (Table 2)
The average age that respondents reported that they had first
used cannabis was 18 years – this was true for both males and
females. Younger respondents aged 15 to 34 reported a lower
average age of first use of 17 years whilst older respondents
reported an average age of first use of 20 years.
First regular use (Table 2)
The average age of first regular use was 18 years for males 
and 17 years for females. Younger respondents aged 15 to 34
reported first using regularly at 17 years while the corresponding
figure for older respondents in the 35 to 64 age-group was 
19 years.
The period of time between first using cannabis and becoming 
a regular user was two years in all instances.
Frequency of use (Table 3)
Frequency of use for all respondents decreased over each 
time period with lifetime prevalence (Table 1) at 17%, 
(less than 1 in 6) and last month prevalence at 3% (1 in 33).
However, 1% of respondents aged 35 to 64 who have ever
used cannabis, have used in the last month, compared to 4% 
of those aged 15 to 34 (Table 1).
More than two in five (41%) current users use cannabis less
than once per week, one in five (22%) use cannabis at least
once per week whilst 14% use cannabis several times per week.
Almost a quarter (22%) of current users have used cannabis 
on a daily or almost daily basis. However, when broken down 
by gender, more than a quarter of males (27%) compared to
one in ten females (11%) reported using cannabis on a daily 
or almost daily basis.
Of the current cannabis users almost a quarter of younger
respondents (23%) compared to one in five (21%) of older
respondents reported taking cannabis on a daily or almost 
daily basis.
Type of cannabis used (Table 4)
Hash was the most commonly used form of cannabis – 
used by the majority (68%) of current users aged 15 to 64 –
this was also true for both males (68%) and females (67%).
Both younger respondents (71%) and older respondents (57%)
also said that they most commonly used hash.
Method by which cannabis is used (Table 5)
The majority of current users (98%) consume cannabis using 
a joint. A higher proportion of male respondents (99%) than
females (96%) reported using a joint whilst a higher proportion
of females (5%) than males (3%) reported eating cannabis.
Older adults (35 to 64) are less likely than younger adults 
(15 to 34) to use a pipe to take cannabis (4% compared 
to 7% respectively) or a bong (4% and 6% respectively).
How cannabis was obtained (Table 6)
All respondents who said they had used cannabis in the last
twelve months were asked how they had obtained their drugs 
on the last occasion. One third of respondents (31%) were 
given cannabis by a family member or friend, a further 27% 
said they had shared cannabis amongst a group of friends. 
A small number of people, 1%, reported buying cannabis 
from a stranger.
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A third of females (33%) compared to a quarter of males 
(24%) reported sharing cannabis amongst friends, while almost
a quarter of males (24%) compared to 11% of females bought
cannabis from a friend. Four percent of females used cannabis 
that had been given to them by a stranger compared with 3% 
of males.
One in three younger respondents (30%) compared to one 
in eight (15%) of older respondents shared cannabis amongst
friends. Thirty two percent of older adults, compared with 17% 
of young adults, bought cannabis from a friend. Eighteen percent
of older respondents, compared to 16% of younger respondents,
bought cannabis from a contact not known to them personally.
Where cannabis was obtained (Table 7)
Respondents who had recently taken cannabis were asked
where they had obtained it on the last occasion that they had
used it. Almost three in five respondents (57%) said they had
obtained cannabis at the house of a friend, whilst 20% had
obtained it at a disco/club/bar and 13% said that they had
obtained cannabis in the street or park.
Almost one in six male respondents (17%) compared to 4% 
of female respondents obtained cannabis in the street or park.
7% of older respondents and 8% of younger respondents
obtained cannabis by ordering it by telephone whilst 9% of
younger respondents obtained cannabis from the house of 
a dealer. No respondents from the older age group reported
obtaining cannabis in this way.
Ease of obtaining cannabis (Table 8)
The vast majority of respondents (79%) considered it ‘very easy’
or ‘fairly easy’ to obtain cannabis within a 24 hour period. This
was true for both male (82%) and female (71%) respondents
and for both younger and older respondents (79%).
Stopping cannabis use and reasons 
for stopping (Tables 9 & 10)
Over a quarter (27%) of respondents who said that they 
had ever taken cannabis said that they had used it regularly.
Of these, almost three in five (58%) said that they had stopped
taking cannabis, one in eight (12%) said that they had tried to
stop and failed, whilst three in ten respondents (30%) said that
they had never tried to stop.
Half of female respondents (52%) compared to three in five
male respondents (60%) said that they had stopped taking
cannabis, whilst three in ten (29%) males and a third of 
females (34%) said that they had never tried to stop. More
women (14%) than men (11%) had tried to stop taking
cannabis but failed.
Two thirds of older respondents (67%) compared to more than
half (55%) of younger respondents said that they had stopped
taking cannabis, whilst a quarter (25%) of older respondents
stated that they had never tried to stop compared to almost 
a third (32%) of younger respondents.
Of those regular users who stopped using cannabis, around 
four in ten (43%) said that it was because they did not want 
to take it anymore. A quarter (26%) said they stopped because
cannabis was no longer part of their social life, almost a quarter
(23%) stopped because they did not enjoy the after effects,
whilst one in five (20%) said that they stopped using cannabis
for health reasons.
One in ten (10%) males said they stopped using cannabis due
to the impact on their job/friends and family, whilst one in five
females (20%) stopped taking cannabis due to pregnancy.
One in ten younger respondents (10%) compared to 3% of
older respondents said they stopped due to cost whilst one in
seven (14%) older respondents said they stopped due to a less
available supply compared to only 1% of younger respondents.
Attitudes towards cannabis use (Table 11)
All those surveyed who had heard of cannabis were asked 
about their attitudes regarding cannabis use. The attitudes of this
group were then compared with the attitudes of two mutually
exclusive groups – those who said that they had used cannabis
at some stage in their lives and those who said that they had
never used cannabis.
In general, those who had ever used cannabis had more liberal
views to the use of cannabis for both medical and recreational
use and they felt that there was less risk to those who smoked
cannabis on a regular basis.
A large majority (72%) of those surveyed felt that cannabis 
use should be permitted for medical reasons. Almost all (91%)
of those who had ever used cannabis compared to seven in 
ten (69%) of those who had never used cannabis, felt that
cannabis use should be permitted for medical reasons. For both
groups, males (93% and 72% respectively) were more likely 
to agree than females (89% and 66% respectively) and older
respondents (96% and 70% respectively) were more likely to
agree than younger respondents (89% and 67% respectively).
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In contrast, only 21% of respondents agreed that cannabis use
should be permitted for recreational purposes. Thirteen percent
of those who had never used cannabis agreed that recreational
use should be permitted, compared to 61% of those who had
ever used the drug. For both groups, males (15% and 66%
respectively) were more likely to agree to its recreational use
than females (11% and 53% respectively).
Respondents were also asked to rate their level of disapproval 
to the occasional use of cannabis – over three quarters (79%)
of respondents who had never used cannabis compared to less
than a quarter (23%) of those who had ever used cannabis,
disapproved of people smoking cannabis occasionally. For both
groups, females (80% and 29% respectively) were more likely 
to disapprove than males (77% and 20% respectively).
Risk perception (Table 11)
When asked about the risk involved in the use of drugs, two 
in three (64%) respondents who had never used cannabis
compared to a quarter (25%) of respondents who had ever
used cannabis, felt that there was a great risk in smoking
cannabis regularly.
Males and females who had never used cannabis were more
than twice as likely (59% and 68% respectively) as males 
and females who have ever used cannabis (23% and 27%
respectively) to perceive cannabis use as a ‘great risk’. In general
males were less likely to perceive cannabis use as a ‘great risk’
than females.
Both younger respondents (56%) and older respondents 
(70%) who had never used cannabis felt that there was 
a ‘great risk’ from regular cannabis use compared to the
corresponding respondents (23% and 27% respectively) 
who had ever used cannabis.
Profile of cannabis users
Gender (Table 12)
The results of all three chi-square tests were statistically
significant. This indicates that there is an association between
gender and cannabis use. Males are more likely than females 
to have ever used cannabis, used it in the last twelve months
and used it in the last month.
Age (Table 13)
The results of all three chi-square tests were statistically
significant. This indicates that there is an association between 
age and cannabis use. Younger respondents (15-34) report
more cannabis use than older respondents (35-64) across 
all three prevalence categories.
Socio-Economic Group2 (Table 14)
The results of two of the three chi-square tests were 
statistically significant. This indicates that there is an association
between socio-economic group (SEG) and cannabis use for 
both lifetime and last month use. Respondents from SEG C1 
(Junior management and owners of small businesses) had
higher lifetime and last month prevalence rates than expected
whereas respondents from SEG C2 (Skilled manual workers 
and manual workers responsible for other workers) and SEG 
D (Semi-skilled and unskilled manual workers, trainees and
apprentices) had lower lifetime prevalence rates than expected.
Work status (Table 15)
The results of all three chi-square tests were statistically
significant. This indicates that there is an association between
work status and cannabis use. Respondents who were in paid
work had higher lifetime prevalence rates than expected whereas
respondents that were not in paid work had a lower lifetime 
and last year prevalence rate than expected. Students had 
higher last year and last month prevalence rates than expected.
Housing tenure (Table 16)
The results of the three chi-square tests were statistically
significant. This indicates that there is an association between
housing tenure and cannabis use. Respondents who rented their
property from a private landlord and from a Local Authority/
Housing Association had higher than expected prevalence rates
for lifetime, last year and last month prevalence rates, whereas
respondents who owned their home had lower prevalence 
rates than expected.
Age education ceased (Table 17)
The result of one of the chi-square tests was statistically significant.
This indicates that there is an association between lifetime
prevalence rates and age education ceased, but not between
recent or current use and age education ceased. Respondents
who left education aged 20 years or older had higher prevalence
rates than expected whereas respondents who had left education
as teenagers had lower prevalence rates than expected.
Education level (Table 18)
The results of two of the chi-square tests were statistically
significant. This indicates that there is an association between
lifetime and recent prevalence rates and education level attained;
with those who have a third level education having higher than
expected prevalence rates.
Bulletin 3
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Northern Ireland
Prevalence of cannabis use (Table 19)
Almost one in six respondents (17%) aged 15 to 64 reported
that they had taken cannabis at some time in their lives, with 
5% having used in the last year and 3% having used in the 
last month.
Age (Table 19)
Overall, prevalence rates were higher among younger
respondents – the lifetime prevalence for those aged 15 to 
34, at 25%, was more than double the rate for those aged 35 
to 64 (10%). The last year prevalence rate for those aged 15 
to 34, at 10%, was 5 times that for those aged 35 to 64 (2%).
Similarly, the rate for last month use was 5 times higher for 
those aged 15 to 34 (5%) than for those aged 35 to 64 (1%).
Gender (Table 19)
Male respondents reported higher prevalence rates than females
across all time periods. The lifetime prevalence figure for males
was 23% compared to 11% for females. Similarly, the figures 
for last year prevalence rates were males 9% and females 
2% whilst last month prevalence rates were males 5% and
females 1%.
First use (Table 20)
The average age respondents reported that they had first used
cannabis was 18 years. Females were slightly older at 19 years
compared to males at 18 years. Younger respondents aged 
15 to 34 reported a lower average age of first use at 17 years 
whilst older respondents reported an average age of first use 
of 21 years.
First regular use (Table 20)
The average age of first regular use was reported as 18 years 
old – this was the same for males, but was 19 for females. 
As with age of first use, younger respondents aged 15 to 34
reported an average age of first regular use of 18 years,
compared to an average age of 23 years for those aged 
35 and over.
The period of time between first using cannabis and becoming 
a regular user was 2 years across all groups except females
where the lag was 1 year.
Frequency of use (Table 21)
Frequency of use for all respondents decreased over time with
lifetime prevalence (Table 19) at 17% and last month
prevalence at 3%. One percent of those aged 35 to 64 who
have ever used cannabis, have used in the last month,
compared to 5% of those aged 15 to 34.
Over a quarter (28%) of current users use cannabis less than
once a week whilst one in five (21%) use cannabis at least 
once a week.
Almost a third (31%) said that they used cannabis on a daily 
or almost daily basis. However, when broken down by gender, 
a third of males (33%) compared to one in six females (16%)
reported using cannabis on a daily or almost daily basis.
Three in ten (30%) younger respondents who are current 
users, compared to a third (34%) of older respondents who 
are current users, reported taking cannabis on a daily or almost
daily basis.
Type of cannabis used (Table 22)
Resin was the most commonly used form of cannabis – 
it was the type selected by almost half (47%) of current users
aged 15 to 64. Resin was also the most common type used 
by males (50%) whilst grass was the most common type used
by females (29%).
Whilst resin was the most common type used by both younger
and older respondents, one in eight (13%) younger respondents
used weed.
Method by which cannabis is used 
(Table 23)
The majority of current users (91%) consume cannabis in the
form of a joint. This was true for both male (91%) and female
(93%) respondents and for younger (90%) and older (95%)
respondents.
How cannabis was obtained (Table 24)
All respondents who said they had used cannabis in the last
twelve months were asked how they had obtained their drugs 
on the last occasion. Two in five (39%) said that they shared
cannabis among a group of friends, a further 23% bought it 
from a friend.
Two in five males (41%) compared to a third of females (33%)
shared cannabis among friends. One in ten females (10%)
compared to 3% of males used cannabis that had been 
given to them by a stranger.
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Two in five older respondents (42%) said that they shared
cannabis among a group of friends. The figure was slightly 
lower for younger respondents (39%). Six percent of younger
respondents had used cannabis given to them by a stranger.
Where cannabis was obtained (Table 25)
Respondents who had recently taken cannabis were asked 
where they had obtained the drug. Over half (55%) said they
had obtained cannabis at the house of a friend, whilst 12% had
obtained it in the street or park and 14% at a disco/club/bar.
Almost one in six female respondents (16%) compared to 
one in seven male respondents (14%) obtained cannabis in 
a disco/bar/pub. Male respondents (14%) were more likely 
than female respondents (7%) to obtain cannabis in a street/
park. One in twelve males (8%) said that they obtained
cannabis by ordering it by telephone.
Nearly two-thirds of older respondents (63%) compared to 
half (53%) of younger respondents said that they had obtained
cannabis at a friend’s house. Almost one in seventeen younger
respondents (6%) obtained cannabis at the house of a dealer.
Ease of obtaining cannabis (Table 26)
The vast majority (91%) of respondents considered it ‘very easy’
or ‘fairly easy’ to obtain cannabis within a 24 hour period. This
was true for both male (92%) and female (86%) respondents
and for both younger (91%) and older (90%) respondents.
Stopping cannabis use and reasons 
for stopping (Tables 27 & 28)
Over a quarter (28%) of respondents who said that they had
ever taken cannabis said that they had used it regularly. Of these,
almost half (48%) said that they had stopped taking cannabis,
one in five (20%) said that they had tried to stop and failed,
whilst a third (33%) said that they had never tried to stop.
Three in five female respondents (61%) compared to two in 
five male respondents (45%) said that they had stopped taking
cannabis, whilst a third of males (33%) and three in ten (29%)
females said that they had never tried to stop.
Almost three in five older respondents (57%) compared 
to more than two in five younger respondents (46%) said 
that they had stopped taking cannabis, whilst around a third 
of respondents from both age groups (33% and 32%
respectively) said that they had never tried to stop.
Two in five regular users (42%) who stopped using cannabis
said they stopped because they did not want to take it any 
more. More than a quarter (26%) cited health concerns as 
their reason for stopping using cannabis, whilst a quarter of
respondents (25%) said they stopped because cannabis was 
no longer part of their social life. One in five (20%) said they
stopped because they did not enjoy the after effects.
Almost half of males (45%) compared to almost a third of
females (30%) who stopped taking cannabis said they did not
want to take it any more. A third of females (30%) compared 
to one in six males (17%) said they did not enjoy the after
effects, whilst 19% of women stopped taking cannabis due 
to pregnancy. One in eight males (12%) said that they 
stopped using cannabis due to cost.
A quarter of younger respondents (25%) compared to 4% of
older respondents said they stopped because they did not enjoy
the after effects.
Attitudes towards cannabis use (Table 29)
All those surveyed who had heard of cannabis were asked 
about their attitudes regarding cannabis use. The attitudes 
of this group were then compared with the attitudes of two
mutually exclusive groups – those who said that they had used
cannabis at some stage in their lives and those who said that
they had never used cannabis.
In general, those who had ever used cannabis had more liberal
views to the use of cannabis for both medical and recreational
use and they felt that there was less risk to those who smoked
cannabis on a regular basis.
Almost all (94%) of those who had ever used cannabis
compared to three quarters (76%) of those who had never 
used cannabis, felt that cannabis use should be permitted 
for medical reasons. For both groups, males (96% and 78%
respectively) were more likely to agree than females (91% 
and 74% respectively) and older respondents (97% and 
78% respectively) were more likely to agree than younger
respondents (93% and 73% respectively).
Two in three (63%) of those who had ever used cannabis
compared to one in seven (14%) respondents who had 
never used cannabis, felt that cannabis use should be permitted
for recreational reasons. For both groups, males (68% and 
18% respectively) were more likely to agree than females 
(54% and 11% respectively) whilst younger respondents 
(63% and 16% respectively) were slightly more likely to 
agree than older respondents (63% and 13% respectively).
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Respondents were also asked to rate their level of disapproval 
to the occasional use of cannabis – three quarters (75%) of
respondents who had never used cannabis compared to one in
five (20%) of those who had ever used cannabis, disapproved of
people smoking cannabis occasionally. For both groups, females
(77% and 26% respectively) were more likely to disapprove
than males (72% and 17% respectively).
Risk perception (Table 29)
When asked about the risk involved in the use of drugs, three 
in five (61%) respondents who had never used cannabis
compared to less than a quarter (23%) of respondents who 
had ever used cannabis felt that there was a great risk in
smoking cannabis regularly.
Males and females who had never used cannabis were more than
twice as likely (55% and 65% respectively) as males and females
who have ever used cannabis (22% and 25% respectively) to
perceive cannabis use as a ‘great risk’. In general males were 
less likely to perceive cannabis use as a ‘great risk’ than females.
Both younger respondents (52%) and older respondents (66%)
who had never used cannabis felt that there was a ‘great risk’ from
regular cannabis use compared to the corresponding respondents
(24% and 22% respectively) who had ever used cannabis.
Profile of cannabis users
Gender (Table 30)
The results of three chi-square tests were statistically significant,
showing an association between gender and cannabis use. 
This indicates that males are more likely to use or have used
cannabis than females.
Age (Table 31)
The results of the three chi-square tests were statistically significant.
This indicates that there is an association between age and
cannabis use. Younger people (15-34) are more likely to use 
or have used cannabis than older respondents (35-64).
Socio-Economic Group3 (Table 32)
The results of two of the chi-square tests were statistically significant.
This indicates that there is an association between socio-economic
group (SEG) and cannabis use for both lifetime and last month
use. Respondents from SEG B (Middle Management, Senior 
Civil Servants, Managers and Owners of Businesses) had lower 
lifetime and last month prevalence rates than expected whereas
respondents from SEG C1 (Junior management and owners 
of small businesses) and SEG C2 (Skilled manual workers and
manual workers responsible for other workers) had higher
lifetime prevalence rates than expected.
Work status (Table 33)
The result of one of the three chi-square tests was statistically
significant. There is an association between work status and
lifetime cannabis use, but not between work status and either
recent or current cannabis use. Respondents who were in 
paid work had a higher prevalence rate than expected whereas
respondents who were not in paid work had a lower prevalence
rate than expected.
Housing tenure (Table 34)
The results of the three chi-square tests were statistically
significant. This indicates that there is an association between
housing tenure and cannabis use. Respondents who rented 
their property from a private landlord had higher prevalence 
rates than expected for lifetime, last year and last month use,
whereas respondents who owned their home had lower
prevalence rates than expected.
Education (Table 35)
The results of the three chi-square tests were statistically
significant. This indicates that there is an association between
levels of education and lifetime, recent and current drug use.
Respondents who had educational qualifications had higher
prevalence rates than expected for lifetime, last year and last
month use, whereas respondents who had no qualifications 
had lower prevalence rates than expected.
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